(Q44699341)

5 December 2017

title

Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice (English)

1 reference

5 December 2017

1 reference

13

1 reference

5 December 2017

12

Masaru Taniguchi

1 reference

5 December 2017

Tsuneaki Homma

1

1 reference

5 December 2017

Shintaro Kinugawa

2

1 reference

5 December 2017

Masashige Takahashi

3

1 reference

5 December 2017

Mochamad Ali Sobirin

4

1 reference

5 December 2017

Akimichi Saito

5

1 reference

5 December 2017

Arata Fukushima

6

1 reference

5 December 2017

Tadashi Suga

7

1 reference

5 December 2017

Shingo Takada

8

1 reference

5 December 2017

Tomoyasu Kadoguchi

9

1 reference

5 December 2017

Yoshihiro Masaki

10

1 reference

5 December 2017

Takaaki Furihata

11

1 reference

5 December 2017

Naoki Ishimori

14

1 reference

5 December 2017

Kazuya Iwabuchi

15

1 reference

5 December 2017

Hiroyuki Tsutsui

16

1 reference

5 December 2017

publication date

14 June 2013

1 reference

Journal of Molecular and Cellular Cardiology

5 December 2017

published in

1 reference

5 December 2017

volume

62

1 reference

5 December 2017

page(s)

179-188

1 reference

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Myocardial reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Ischemia/reperfusion injury: The role of immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

NKT cells: what's in a name?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

7 January 2021

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Akt/GSK-3β/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia-reperfusion injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Cytokines and the microcirculation in ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Status of cytokines in ischemia reperfusion induced heart injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Interleukin-10 and the interleukin-10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

The location of splenic NKT cells favours their rapid activation by blood-borne antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.06.004

10.1016/J.YJMCC.2013.06.004

7 January 2021

Identifiers

DOI

1 reference

release_iajqe4wed5bhdnidzrgydzinbi

5 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iajqe4wed5bhdnidzrgydzinbi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference